These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-000438-35 A study of the Efficacy and Safety of Teduglutide in subjects with Parenteral Nutritional Dependant Short Bowel Syndrome 2007-07-06 due-trials
Not reported 2004-000439-27 A Study of the Safety and Efficacy of Teduglutide in Subjects with Parenteral Nutrition-Dependant Short Bowel Syndrome Who Completed Protocol CL0600-004 2008-01-24 due-trials
Listed as ongoing, but also has a completion date 2008-005063-34 A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone [rhPTH(1-84)] for the Treatment of Adults with Hypoparathyroidi... 2011-09-21 bad-data
Listed as ongoing, but also has a completion date 2008-006193-15 A 24-Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome 2011-02-25 bad-data
Listed as ongoing, but also has a completion date 2009-011679-65 A Long Term, Open Labeled Study with Teduglutide for Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome who completed Study Cl0600020 2013-02-11 bad-data
Not reported 2011-001265-40 A 6-Month Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults with Hypoparathyroidism - A Clinica... 2012-09-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-004588-30 A 12-Week Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects Aged 1 Year through 17 Years, with Short Bowel Syndrome who are Dependent on Parenteral Support 2015-03-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2015-002252-27 A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age with Short Bowel Syndrome who are Dependent on ... 2017-08-18 bad-data
Ongoing 2015-003108-22 An Open-label, Single-dose Study to Determine the Pharmacokinetic/Pharmacodynamic Profile of Parathyroid Hormone (rDNA) Administered Subcutaneously at a Dose of not-yet-due